About This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial and Public Health Labs.    In addition to market share and sales forecasts, the report:-  Examines market applications of Molecular Diagnostics,     Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;-  Reviews features and operating characteristics of major analyzers used    for microbiology testing; -  Profiles key suppliers and potential market entrants developing innovative   technologies and products; and -  Analyzes emerging opportunities, alternative market penetration strategies,    market entry barriers/risks, and strategic planning issues.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.In addition to primary sources of information, a comprehensive review ofthe most recent technical and business publications, manufacturer productand financial literature, as well as Venture Planning Group’s... Research Beam Model: Research Beam Product ID: 15512 2500 USD New
Enteric Diseases in the US 2014: Market Outlook and Emerging Opportunities
 

Enteric Diseases in the US 2014: Market Outlook and Emerging Opportunities

Enteric Diseases in the US 2014: Market Outlook and Emerging Opportunities

Category : Diagnostic and Biotech
Published On : January  2014

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

About This Report

This new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial and Public Health Labs.    

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used 
   for microbiology testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies, 
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.
 
Contains 322  pages and 22  tables



Enquiry Before Buy